- 23 Everett St., Room 323
Sara Gerke is a Visiting Researcher at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. In her research, Sara focuses on two main topics: first, the ethics and law of “in vitro gametogenesis” (IVG) in the United States (US) and Europe and second, U.S. patent and Food and Drug Administration (FDA) law.
Before joining the Petrie-Flom Center, Sara was employed as General Manager of the Institute for German, European and International Medical Law, Public Health Law and Bioethics of the Universities of Heidelberg and Mannheim (IMGB) in Germany. She was also the Co‑Investigator of an interdisciplinary project, known as “ClinhiPS”, sponsored by the German Federal Ministry of Education and Research (funds: 657,678.00 EUR; term: April 2016 to March 2018). This project analyzed the clinical application of human induced pluripotent stem cells (hiPSCs) in Germany and Austria from a scientific, ethical and comparative legal perspective.
Sara was performing these tasks while writing her doctoral thesis in the field of stem cell research at the University of Mannheim, Germany, under the supervision of Professor Dr. Jochen Taupitz. Her thesis focuses on the legal framework for bringing stem cell research to clinical application within the EU, particularly with regard to German and UK law. Sara expects her doctorate to be officially awarded in late 2018 or early 2019.
From July 2015 to March 2016, Sara spent nine months as a visiting PhD student at Durham University in England to undertake research under the supervision of Professor Shaun D. Pattinson. Her visit was supported by a scholarship awarded by the German Academic Exchange Service (DAAD).
Sara graduated in law from the University of Augsburg, Germany, in July 2012 with distinction-level results in her First State Examination. She also holds a Master’s degree in Medical Ethics and Law from King’s College London (December 2013).